155 related articles for article (PubMed ID: 15754413)
1. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
[TBL] [Abstract][Full Text] [Related]
2. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
3. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.
Yue H; Na YL; Feng XL; Ma SR; Song FL; Yang B
World J Gastroenterol; 2003 Feb; 9(2):377-80. PubMed ID: 12532471
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.
Yue H; Jiang HY
World J Gastroenterol; 2005 Aug; 11(32):5057-60. PubMed ID: 16124066
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
10. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
Yue H; Yu J; Zhao X; Song F; Feng X
Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
[TBL] [Abstract][Full Text] [Related]
11. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
13. [Determination of expression of eight p53-related genes in hepatocellular carcinoma with tissue microarrays].
Zhu MH; Ni CR; Zhu Z; Li FM; Zhang SM
Ai Zheng; 2003 Jul; 22(7):680-5. PubMed ID: 12866955
[TBL] [Abstract][Full Text] [Related]
14. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
15. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
Xiao EH; Li JQ; Huang JF
World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
[TBL] [Abstract][Full Text] [Related]
16. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
Qin LF; Ng IO; Fan ST; Ng M
Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis.
Guo H; Jing L; Cheng Y; Atsaves V; Lv Y; Wu T; Su R; Zhang Y; Zhang R; Liu W; Rassidakis GZ; Wei Y; Nan K; Claret FX
Hepatology; 2016 Mar; 63(3):898-913. PubMed ID: 26606000
[TBL] [Abstract][Full Text] [Related]
18. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
19. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
20. Antigen p57/Kip2 as a potential negative regulator of human astrocytoma growth.
Akaishi K; Nakayama J; Sakai K; Kobayashi T; Rutka JT
J Clin Neurosci; 2009 Dec; 16(12):1615-8. PubMed ID: 19822429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]